Although the 400-person study was too small to really compare clinical outcomes, Tanigaki said a count of major adverse ...

Mepolizumab has had a bumpy road to arriving at its indication in COPD. An FDA advisory committee in 2018 declined to ...

With all of the healthcare funding cuts currently going on in Washington, there is one health service that has survived ...

The outrage over prescription drug pricing in the U.S. is justified. Americans routinely pay two to three times more for ...

It would impose work requirements for low-income adults to receive Medicaid health insurance and increase them for food ...

By "making T cells happier," the widely used selective serotonin reuptake inhibitor (SSRI) class of antidepressants enhanced ...

While rates of bile duct injury were similar with robotic-assisted cholecystectomy and laparoscopic cholecystectomy among ...

Seven weeks into his job as FDA commissioner, Marty Makary, MD, MPH, held his own answering a barrage of sometimes ...

An FDA advisory committee unanimously recommended Thursday that the next COVID vaccine should be a monovalent one in the JN.1 ...

At the recent American Urological Association annual meeting, data on niraparib (Zejula) in treatment-naive, DNA damage repair (DDR)-deficient localized prostate cancer offered new insights -- but ...

CHICAGO -- Adding the PI3K-pathway inhibitor inavolisib (Itovebi) to palbociclib (Ibrance) and fulvestrant significantly ...